随着体重变化,-葡萄糖共运输体的结局与相关,新用户
Takahiro Jimba1, Hidehiro Kaneko1,2, Tatsuhiko Azegami3
1Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
在开始服用-葡萄糖共运输体-2 (SGLT2) 抑制剂后,较大的体重减轻与糖尿病患者的更好的脏结果有关. 这项研究强调了体重变化对该人口脏健康的临床意义.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- -葡萄糖共运输体-2 (SGLT2) 抑制剂越来越多地用于治疗糖尿病.
- 在SGLT2抑制剂治疗期间体重变化对结局的影响需要进一步调查.
研究的目的:
- 为了确定体重变化对SGLT2抑制剂治疗的糖尿病患者结局的临床意义.
主要方法:
- 使用全国流行病学数据库进行回顾性队列研究.
- 分析包括11,569名糖尿病患者新开处方的SGLT2抑制剂.
- 估计的淋巴细胞过率 (eGFR) 降低使用线性混合效应模型进行评估.
主要成果:
- 参与者按身体质量指数 (BMI) 分层,一年后变化三位数.
- 在BMI变化和eGFR下降之间观察到显著的相互作用 (p < 0.001).
- 较大的BMI下降与较慢的年度eGFR下降相关,表明有利的脏结果.
结论:
- 在SGLT2抑制剂启动后的体重减轻与改善的结局有关.
- 监测和鼓励减肥可能会增强糖尿病患者SGLT2抑制剂对的保护作用.
更多相关视频
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
相关概念视频
Antihypertensive Drugs: Action of Diuretics
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Antihypertensive Drugs: Potassium-Sparing Diuretics
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Regulation of Water Intake
